Global Cell Dissociation Market Size Envisaged to Reach USD 1,161.06 Million By 2032, at 14.0% CAGR: Polaris Market Research

Polaris Market Research conducted a comprehensive research study spanning over [+115] pages, revealing that the global cell dissociation market size/share is expected to reach USD 313.88 Million in 2022. The study further indicates that the market will grow at a compound annual growth rate (CAGR) of 14.0% and is projected to touch USD 1,161.06 Million by 2032. The tissue dissociation segment highly dominates the industry and is projected to maintain its position in the global market. Some of the major players are GE Healthcare, ATCC, Merck KGaA, ALSTEM, CellSystems, REPROCELL Inc., Gemini Bio-Products, Biological Industries USA, Inc., BIOCOM AG, Thermo Fisher Scientific Inc. and others.


New York, NY, May 17, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Cell Dissociation Market Share, Size, Trends, Industry Analysis Report, By Product (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, Instruments, and Accessories); By Type; By Tissue; By Application; By End Use; By Regions; Segment Forecast, 2023 - 2032” in its research database.

“As per the latest research analysis, the global cell dissociation market size/share will be valued at roughly USD 313.88 million in 2022, and its revenue is projected to reach about USD 1,161.06 Million By 2032. The market is forecasted to expand at a compound annual growth rate of approximately 14.0% between 2023 and 2032.”

What is Cell Dissociation? How Big is Cell Dissociation Market?

  • Overview

Dissociation is a mandatory procedure that permits researchers to aim and segregate the kinds of cells they are venturing to study. The rapidly rising demand for the cell dissociation market can be attributed to the fact that the aim is to garner as many feasible cells as attainable without negatively influencing the cell potentiality or function.

Dissociation is an essential methodology that permits researchers to brand and segregates the kinds of cells that they are attempting to study. The global industry is speedily evolving with a broad gamut of products obtainable to assist researchers, pharmaceutical companies, and clinicians in their endeavor to manipulate, study and utilize cells.

Request Sample Copy of Cell Dissociation Market Research Report @ https://www.polarismarketresearch.com/industry-analysis/cell-dissociation-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Our Sample Report Covers:

  • 2032 Updated Report Introduction, Overview, and In-depth industry analysis.
  • 115+ Pages Research Report (Inclusion of Updated Research).
  • Provide Chapter-wise guidance on Requests.
  • 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of tables & figures.
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.

Some of the Top Market Players Are:

  • GE Healthcare
  • ATCC
  • Merck KGaA
  • ALSTEM
  • CellSystems
  • REPROCELL Inc.
  • Gemini Bio-Products
  • Biological Industries USA Inc.
  • BIOCOM AG
  • Thermo Fisher Scientific Inc.
  • BrainBits LLC
  • Pelobiotech
  • Himedia Laboratories
  • Labochema
  • Cyagen Biosciences Inc.
  • PAN-Biotech
  • BIOCOMPARE
  • F. Hoffmann-La Roche Ltd
  • Miltenyi Biotec
  • Sigma-Aldrich Co. LLC Irvine Scientific
  • STEMCELL Technologies Inc.
  • PromoCell GmbH

To Know an Additional List of Key Players, Request Here to Download a Free Report PDF Brochure: https://www.polarismarketresearch.com/industry-analysis/cell-dissociation-market/request-for-sample

Prominent Growth Driving Factors

  • Research and development: Prominent factors that are anticipated to push the growth of the market is the escalation in the requirement for research and development in biopharmaceutical companies. The cell dissociation market size is expanding due to the acceptable financing structure for cancer research and increasing cases of dangerous and communicable illnesses.
  • Advancing markets: The growing likelihood of advancing markets and the growth in the advanced tissue enzyme commodities will additionally offer possible occasions for the development of the market in the coming years.
  • Regenerative medicines: The acceptance of regenerative medicine is escalating, and cell dissociation is an intrinsic part of the separation and beguiling of cells for regenerative therapies. Cell dissociation market sales are soaring due to the increasing consciousness of regenerative medicine is propelling the market growth.
  • Technological progression: The technological progression, escalating demand for cell-based assays and therapies, growing funding in research and development, and increasing acceptance of regenerative medicine are pushing the market growth.

Request Customized Copy of Report @ https://www.polarismarketresearch.com/industry-analysis/cell-dissociation-market/request-for-customization

(We customize your report according to your research need. Ask our sales team for report customization.)

Top Report Findings

  • The growing likelihood of advancing markets and the growth in the advanced tissue enzyme commodities will additionally offer possible occasions for the development of the market in the coming years.
  • The market is essentially segregated into product, type, tissue, application, end-user, and region.
  • The leading region of the market is North America.

Top Trends Influencing the Market

  • Requirement for single cells: The market has encountered notable development in recent years, pushed by the growing demand for cell-based therapies and regenerative medicines. The requirement for single cells or cell collections for research and development in cell biology, biotechnology, and drug recognition has also assisted in the growth of the market.
  • Escalation in clinical trials: Additionally, the surge in the existence of dangerous illnesses has caused an escalation in the aggregate of clinical trials and research studies, including cell-based therapies. These studies require the dissociation of cells from several organs and tissues, additionally fuelling the demand for the products.
  • Acceptance in academic and research organizations: Progression in cell culture technologies have caused the advancement of contemporary and inventive commodities such as enzymes and kits that are more well-planned and productive in cell dissociation. These products are growingly being accepted in academic and research organizations, pharmaceutical and biotech companies, and clinical research firms.

Segmental Analysis

  • The enzymatic dissociation product segment is anticipated to have the largest market share

Based on the product, the enzymatic dissociation product segment is anticipated to have the largest market share. Cell dissociation market demand is on the rise as this strategy uses enzymes to assimilate tissue particles and liberate cells. Many enzymes, either solitary or in amalgamation, can be utilized for this procedure.

  • The tissue dissociation segment will dominate the market

Based on type, the tissue dissociation segment will dominate the market. Cell dissociation market trends include the biopharmaceutical and pharmaceutical firms concentrating on monoclonal antibody advancements and treatment tailoring.

Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/cell-dissociation-market/inquire-before-buying

(Inquire about a report quote OR available discount offers to the sales team before purchase.)

Cell Dissociation Market: Report Scope & Segmentation

Report Attribute Details
Revenue Forecast in 2032 USD 1,161.06 Million
Market size value in 2023 USD 356.76 Million
Expected CAGR Growth 14.0% from 2023 - 2032
Base Year 2022
Forecast Year 2023 – 2032
Top Market Players GE Healthcare, ATCC, Merck KGaA, ALSTEM, CellSystems, REPROCELL Inc., Biological Industries USA, Inc., BIOCOM AG, Thermo Fisher Scientific Inc., BrainBits, LLC, Pelobiotech, Himedia Laboratories, Labochema, PAN-Biotech, BIOCOMPARE, Gemini Bio-Products, F. Hoffmann-La Roche Ltd, STEMCELL Technologies, Inc., Miltenyi Biotec, Cyagen Biosciences, Inc., Irvine Scientific, and Sigma-Aldrich Co. LLC and PromoCell GmbH, etc.
Segments Covered By Product, By Type, By Tissue, By Application, By End User, By Region
Customization Options Customized purchase options are available to meet any research needs. Explore customized purchase options

Geographic Overview

North America: This region held the largest cell dissociation market share due to growing cases of cancer and dangerous illnesses in the region. The increasing approval of R&D in life sciences by academia and industry, with the existence of prominent key players, is anticipated to additionally propel the market's growth in the course of the forecast period.

Asia Pacific: This region is going to evolve speedily predominantly due to escalating demand for contemporary therapeutics. Growing government funding in R&D and speedy framework advancement further reinforces the growth.

Browse the Detail Report “Cell Dissociation Market Share, Size, Trends, Industry Analysis Report, By Product (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, Instruments, and Accessories); By Type; By Tissue; By Application; By End Use; By Regions; Segment Forecast, 2023 - 2032” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/cell-dissociation-market           

For Additional Information OR Media Enquiry, Please Mail At: sales@polarismarketresearch.com

Recent Developments

  • In 2020, on CliniMACS Prodigy, Biotec introduced closed adherent and automated cell culture solutions.
  • In 2020, for the use of STEMCELLs in cell culture applications, STEMCELL Technologies partnered with CollPlant.

Frequently Asked Questions

  • What are the key segments in the market?
  • At what CAGR is the market predicted to grow during the forecast period?
  • Which region is leading the global market?
  • What are the key driving factors in the market?
  • What are the prominent revenue pockets in the market currently?
  • What is the projected market value?

Polaris Market Research has segmented the Cell Dissociation Market report based on product, type, tissue, application, end-use, and region:

By Product Outlook

  • Enzymatic Dissociation Products
    • Trypsin
    • Collagenase
    • Elastase
    • Papain
    • Hyaluronidase
    • DNase
    • Others
  • Non-Enzymatic Dissociation Products
  • Instruments and Accessories

By Type Outlook

  • Tissue Dissociation
  • Cell Detachment

By Tissue Outlook

  • Connective Tissue
  • Epithelial Tissue
  • Others

By Application Outlook

  • Antibody Production
  • Veterinary Applications
  • Cell Culture Maintenance
  • Immunoassays

By End Use Outlook

  • Pharmaceutical and Biotechnological Companies
  • Research and Academic Institutes
  • Others

By Region Outlook

  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Browse More Research Reports:

About Polaris Market Research:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavour to deliver value-added business solutions to PMR’s customers.

Contact:

Likhil G

30 Wall Street

8th Floor,

New York City, NY 10005,

United States

Phone: +1-929 297-9727

Email: sales@polarismarketresearch.com

Web: https://www.polarismarketresearch.com

Follow Us: LinkedIn Twitter

Blog: https://polarismarketresearch.medium.com | https://polarisnewsblog.com